Therefore, further investigations could potentially unearth new biomarkers for AD, including NETs, myeloperoxidase (MPO), neutrophil gelatinase-associated lipocalin (NGAL), and the neutrophil-to-lymphocyte ratio (NLR). Here, MPO is linked to Alzheimer disease.